Equol: A Bacterial Metabolite from The Daidzein Isoflavone and Its Presumed Beneficial Health Effects.
Mayo B, Vázquez L, Flórez AB. · 2019
Read Equol: A Bacterial Metabolite from The Daidzein Isoflavone and Its Presumed Beneficial Health Effects. by Mayo B, Vázquez L, Flórez AB. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6770660.txt.
Description
Mayo and co-authors review equol, a compound gut bacteria make from soy. Soy isoflavones are linked to lower rates of menopause symptoms, osteoporosis, heart disease, and cancer. Equol, made from the isoflavone daidzein, has the strongest estrogen-like and antioxidant activity of the group. It may carry much of soy's benefit.
Only gut microbes can produce equol, using reductase enzymes. All animal species tested make it, but only one third to one half of people do. The rest lack the right microbes. The review covers the bacteria, genes, and pathways behind production. It also weighs clinical trials and meta-analyses on equol's health effects, and how it might act in the body.
Catalog record
| CREATOR | Mayo B, Vázquez L, Flórez AB. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 78 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |